Abstract
Adenosine (Ado) is an important mediator of the endogenous defense against ischemia-induced injury in the heart. The action of Ado is mediated by activation of G protein-gated inwardly rectifying K(+) (GIRK) channels. In turn, GIRK channels are inhibited by reducing phosphatidylinositol 4,5-bisphosphate (PIP(2)) through Gq protein-coupled receptors (GqPCRs). We previously found that GIRK channels activated by acetylcholine, a muscarinic M2 acetylcholine receptor agonist, are inhibited by GqPCRs in a receptor-specific manner. However, it is not known whether GIRK channels activated by Ado signaling are also regulated by GqPCRs. Presently, this was investigated in mouse atrial myocytes using the patch clamp technique. GIRK channels were activated by 100 microM Ado. When Ado was repetitively applied at intervals of 5~6 min, the amplitude of second Ado-activated GIRK currents (I(K(Ado))) was 88.3+/-3.7% of the first I(K(Ado)) in the control. Pretreatment of atrial myocytes with phenylephrine, endothelin-1, or bradykinin prior to a second application of Ado reduced the amplitude of the second I(K(Ado)) to 25.5+/-11.6%, 30.5+/-5.6%, and 96.0+/-2.7%, respectively. The potency of I(K(Ado)) inhibition by GqPCRs was different with that o...Continue Reading
References
Mar 1, 1992·Circulation·S W Ely, R M Berne
Aug 1, 1990·Circulation·G C LiB R Lucchesi
Sep 1, 1986·Pflügers Archiv : European journal of physiology·Y KurachiT Sugimoto
Nov 1, 1989·Circulation·D G BabbittM B Forman
Nov 1, 1987·Circulation·B OlafssonR Virmani
Nov 1, 1986·Circulation·C E MurryK A Reimer
May 19, 1983·Nature·B SakmannW Trautwein
Mar 1, 1995·Basic Research in Cardiology·G J Gross
Jan 1, 1995·The Journal of Physiology·M Bünemann, L Pott
Mar 9, 1995·Nature·G KrapivinskyD E Clapham
Mar 1, 1995·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·L BelardinelliM Srinivas
Aug 26, 1993·Nature·Y KuboL Y Jan
Jun 10, 1997·Proceedings of the National Academy of Sciences of the United States of America·G P MatherneJ P Headrick
Jun 1, 1997·Journal of Molecular and Cellular Cardiology·A Clerk, P H Sugden
Mar 14, 1998·Proceedings of the National Academy of Sciences of the United States of America·J L SuiD E Logothetis
Mar 28, 1998·The Journal of Biological Chemistry·G B WillarsR A Challiss
Mar 5, 1998·Nature·C L HuangD W Hilgemann
Nov 2, 1999·The Journal of Physiology·I H Ho, R D Murrell-Lagnado
Nov 13, 1999·Nature Cell Biology·H ZhangD E Logothetis
Mar 8, 2000·Biochimica Et Biophysica Acta·A ArbuzovaS McLaughlin
Apr 4, 2000·Circulation Research·M C Wellner-KienitzL Pott
Oct 13, 2000·The Journal of Biological Chemistry·H ChoW K Ho
Oct 24, 2001·European Journal of Pharmacology·H ChoW K Ho
Jan 24, 2002·The Journal of Pharmacology and Experimental Therapeutics·Mitsuhiko Yamada
May 23, 2002·The Journal of Biological Chemistry·Hana ChoWon-Kyung Ho
Jan 7, 2003·The Journal of Biological Chemistry·Dirk SchulzeThomas Baukrowitz
May 25, 2004·The Journal of Biological Chemistry·Xiaona DuDiomedes E Logothetis
Mar 16, 2005·Proceedings of the National Academy of Sciences of the United States of America·Hana ChoWon-Kyung Ho
Dec 16, 2006·Current Pharmaceutical Design·Toru Kobayashi, Kazutaka Ikeda
Jan 27, 2007·The Journal of Physiology·Jong-Woo SohnWon-Kyung Ho
Jun 23, 2007·The Journal of Physiology·Jong-Woo SohnWon-Kyung Ho